Tsai Philip bought IMNM
July 23, 2026 · Form 4 insider transaction
Tsai Philip bought 38,250 shares of Immunome, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,250
Price
$0.00
Total value
N/A
InsiderTsai Philip
RoleOfficer
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after81,550
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.